Skip to main content
Stevanato Group S.p.A. (STVN)
NYSE: STVN · Real-Time Price · USD
18.97
-0.69 (-3.51%)
Oct 4, 2024, 4:00 PM EDT - Market closed

Stevanato Group Revenue

Stevanato Group had revenue of 259.58M EUR in the quarter ending June 30, 2024, with 1.67% growth. This brings the company's revenue in the last twelve months to 1.09B, up 5.53% year-over-year. In the year 2023, Stevanato Group had annual revenue of 1.09B with 10.34% growth.

Revenue (ttm)
1.09B EUR
Revenue Growth
+5.53%
P/S Ratio
4.35
Revenue / Employee
193,048 EUR
Employees
5,634
Market Cap
5.18B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.09B101.67M10.34%
Dec 31, 2022983.68M139.76M16.56%
Dec 31, 2021843.92M181.88M27.47%
Dec 31, 2020662.04M125.50M23.39%
Dec 31, 2019536.54M514.54M2,338.37%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Option Care Health 4.59B
DENTSPLY SIRONA 3.90B
PACS Group 3.56B
Acadia Healthcare Company 3.06B
RadNet 1.71B
Merit Medical Systems 1.30B
Ionis Pharmaceuticals 813.46M
Blueprint Medicines 362.80M
Revenue Rankings

STVN News

More News